Venture

Cognito Therapeutics Group, Inc.

Latest Form D 2025-04-01
  • CIK 2062885
  • State MA
  • Other Health Care
  • 1 Form D offering since 2025-04-01
Total sold
$196M
across its one offering
Rounds
1
Form D offerings since 2025-04-01
Latest round
$196M
2025-04-01 · 021-542681
Investors
23
on the latest round

Connected

named in its Form D filings

Round timeline

amount sold · by first filed
2025-04-01 · $196M
  1. 2025-04-01$196M021-542681

Hover a dot or row, or tab through the dots · bars scaled to the largest round ($196M)

Form D offerings

One line per offering, amendments folded in, newest first

Form D offerings
FileFirst filedLatestSoughtSoldInvestorsExemptions
021-542681First filed2025-04-01Latest2025-04-01Sought$196MSold$196MInvestors23Exemptions506(b)
Who backs Cognito Therapeutics Group, Inc., inferred from co-filings, and every Form D as filedSee plans

People

Named in Item 3 of its latest Form D, filed 2025-04-01

Related persons
NameRelationship
Christian HowellRelationshipExecutive Officer, Director
Gerald ChanRelationshipDirector
Stephen BrusoRelationshipDirector
Helen LiangRelationshipDirector
Richard KuntzRelationshipDirector
Laura BregeRelationshipDirector
Jarod RutledgeRelationshipDirector

Facts

As its latest Form D states them

Industry
Other Health Care
State
Massachusetts (MA)
Exemptions
Rule 506(b)
First filed
2025-04-01
Latest filing
2025-04-01

Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.

  • Inferred investors — the funds and firms behind it, from co-filings and shared people
  • Every Form D and amendment as filed, with what each one stated
  • Its rounds in sequence: the gap between them and whether they grew
  • Everyone its filings name, linked to their other companies, with its addresses and phone numbers

Part of the Venture plan — $140/mo at launch pricing ($350 list)

See plans

External link: SEC Filings ↗